Optimizing Perioperative Venous Thromboembolism Chemoprophylaxis on a Gynecologic Oncology Service

J Am Coll Surg. 2022 Aug 1;235(2):306-314. doi: 10.1097/XCS.0000000000000253. Epub 2022 Apr 27.

Abstract

Background: Perioperative venous thromboembolism (VTE) is a significant cause of morbidity and mortality after gynecologic cancer surgery. Here we report a quality improvement intervention to increase perioperative VTE chemoprophylaxis compliance.

Study design: All operations performed by a gynecologic oncologist at a tertiary urban university medical center admitted to the hospital for at least one midnight were included. Using a pre/post design with a washout period, we sought to increase perioperative VTE chemoprophylaxis compliance from 22% in the historical control (HC) cohort to 90% in the quality improvement (QI) cohort. The perioperative VTE chemoprophylaxis process was standardized by addressing four domains: preoperative VTE chemoprophylaxis, surgical time-out, postoperative VTE chemoprophylaxis, and intervention education and compliance tracking. Pearson's chi-square test was used to compare HC vs QI cohort compliance.

Results: There were 130 surgical cases in the HC cohort and 131 in the QI cohort. Forty-two percent underwent laparotomy, and 57% had cancer at the time of operation. VTE chemoprophylaxis compliance improved from 22% in the HC cohort to 82% in the QI cohort (p < 0.001). Preoperative VTE chemoprophylaxis compliance improved from 76% in the HC cohort to 94% in the QI cohort (p < 0.001), and postoperative VTE chemoprophylaxis compliance improved from 27% to 87% (p < 0.001). Thirty-day postoperative VTE occurred in three patients (2%) in the HC cohort and none in the QI cohort (p = 0.08).

Conclusions: A low-cost and low-technology QI initiative intervention improved perioperative compliance with VTE chemoprophylaxis.

MeSH terms

  • Anticoagulants / therapeutic use
  • Chemoprevention / adverse effects
  • Cohort Studies
  • Female
  • Genital Neoplasms, Female* / complications
  • Genital Neoplasms, Female* / drug therapy
  • Genital Neoplasms, Female* / surgery
  • Humans
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control
  • Quality Improvement
  • Retrospective Studies
  • Venous Thromboembolism* / drug therapy
  • Venous Thromboembolism* / etiology
  • Venous Thromboembolism* / prevention & control

Substances

  • Anticoagulants